Patent · US Active

Malaria vaccine and methods for producing same

US10940190B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 23, 2018
Grant dateMar 9, 2021
Priority date
Expiry dateFeb 23, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present description relates to malaria vaccines comprising Plasmodium falciparum (Pf) polypeptide complexes and methods of producing the same. The Pf polypeptides in complexes or in a partially complexed arrangement may comprise two or more of the following polypeptides: PfRipr, PfCyrPa and PfRh5. Drosophila cells and expression vectors are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.